Colomine®/Colomine-OD®


Mesalamine Delayed Release Tablet / Mesalamine Prolonged Release Tablet

Aminosalicylate Gastro-intestinal Anti-inflammatory Drug



Indication:

Ulcerative Colitis: For the treatment of mild to moderate, active acute exacerbations. For the maintenance of remission.
Crohn’s ileo-colitis: For the maintenance of remission.


Dosage & Administration:

For COLOMINE:
Mild acute exacerbations of ulcerative colitis: 2.4g a day in divided doses.
Moderate acute exacerbations of ulcerative colitis: 2.4g to 4.8g a day in divided doses.
Maintenance of remission of ulcerative colitis: 1.6g to 2.4g a day once daily or in divided doses.
Maintenance of remission of Crohn’s ileo-colitis: 2.4 g a day in divided doses.
The maximum adult dose should not exceed 6 tablets a day and not exceed 3 tablets taken together at any one time.
For COLOMINE-OD:
2-4 tablets (2.4 to 4.8g) once daily for induction of remission. And two tablets (2.4 g) once daily for maintenance of remission. Not recommended to children below 18 years.


Preparation:

Colomine® 400 tablet: Each box contains 10 x 20 tablets in blister pack.
Colomine® 800 tablet: Each box contains 10 x 10 tablets in blister pack.
Colomine-OD® tablet: Each box contains 10 x 10 tablets in blister pack.